JAK2 inhibitors improve RA combined with pulmonary fibrosis in rats by downregulating SMAD3 phosphorylation

Y Wei, D Wang, J Wu, J Zhang - International Journal of …, 2024 - Wiley Online Library
Background JAK inhibitors are well known for the treatment of rheumatoid arthritis (RA), but
whether they can be used to treat pulmonary fibrosis, a common extra‐articular disease of …
相关文章

JAK2 inhibitors improve RA combined with pulmonary fibrosis in rats by downregulating SMAD3 phosphorylation.

Y Wei, D Wang, J Wu, J Zhang - International Journal of Rheumatic …, 2024 - europepmc.org
Background JAK inhibitors are well known for the treatment of rheumatoid arthritis (RA), but
whether they can be used to treat pulmonary fibrosis, a common extra-articular disease of …

JAK2 inhibitors improve RA combined with pulmonary fibrosis in rats by downregulating SMAD3 phosphorylation

Y Wei, D Wang, J Wu, J Zhang - International journal of …, 2024 - pubmed.ncbi.nlm.nih.gov
Background JAK inhibitors are well known for the treatment of rheumatoid arthritis (RA), but
whether they can be used to treat pulmonary fibrosis, a common extra-articular disease of …